Key Takeaways
- • Oak Hill Capital-backed Petauri has acquired Emotive, a global medical communications agency, adding it to its healthcare services platform, according to PEI Private Equity.
- • Emotive was founded in 2013 and has particular depth in neuroscience and immunology, with additional experience in oncology and rare disease.
- • The deal is a platform add-on, expanding Petauri's scientific communications capabilities in therapeutic areas with complex regulatory and clinical needs.
Summary
Petauri, a healthcare services platform backed by Oak Hill Capital, has added Emotive, a global medical communications agency, according to a brief published by PEI Private Equity. The article was categorized under deals in North America and healthcare, and the publisher's summary frames the transaction as a platform add-on.
Emotive was founded in 2013. The source describes the firm as having particular depth in neuroscience and immunology, alongside experience in oncology and rare disease. These therapeutic areas typically require specialized scientific expertise in medical education, publication planning and pharmaceutical communications, which suggests the acquisition is intended to broaden Petauri's offering in complex specialty categories.
The primary source does not disclose the purchase price, deal terms or the size of Emotive's revenue or headcount. Investors tracking the medical communications sector should consider those details unavailable from this report pending further disclosure.
Emotive was founded in 2013. The source describes the firm as having particular depth in neuroscience and immunology, alongside experience in oncology and rare disease. These therapeutic areas typically require specialized scientific expertise in medical education, publication planning and pharmaceutical communications, which suggests the acquisition is intended to broaden Petauri's offering in complex specialty categories.
The primary source does not disclose the purchase price, deal terms or the size of Emotive's revenue or headcount. Investors tracking the medical communications sector should consider those details unavailable from this report pending further disclosure.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.